N@N

EPAY, ZIXI, FNSR, KWR, NKTR, JLL, Expected to Trade Lower After Bearish Insider Trading

May 19, 2017 / M2 PRESSWIRE / BUYINS.NET / http://www.squeezetrigger.com is monitoring top insider trading patterns and these stocks are the most likely to trade Lower in the next 6 months. Bottomline Technologies, Inc. (NASDAQ:EPAY), Zix Corporation (NASDAQ:ZIXI), Finisar Corporation (NASDAQ:FNSR), Quaker Chemical Corporation (NYSE:KWR), Nektar Therapeutics (NASDAQ:NKTR), Jones Lang Lasalle Inc. (NYSE:JLL) are all expected to go Lower as Sell signals have been generated by top insider trading patterns. The most important data elements considered when performing insider analysis are: Insiders Track Record - An insiders track record is best summarized by the Insider Score which ranges from 1 (least predictive) to 100 (most predictive) based on prior trading performance. In addition, the actual returns following the insiders prior trades are included to determine the potential magnitude of future returns. Insiders Role - Trades by higher-level insiders are generally more predictive than trades by lower level insiders. Higher-level insiders to include Chairman (CB), Chief Executive Officer (CEO), President (P), Chief Financial Officer (CFO), and Vice Chairman (VC).

The chart below displays the stocks expected to go Lower along with the insider name, position, predictive insider score, 6 month expected return and number of trading decisions included in the score.

  Symbol  Company Name                     Insider Name                     Role     Shares      Insider Score  Avg 6 Month Return  # of Dec. 
  EPAY    Bottomline Technologies, Inc.    Kelly, John Francis              O        2,532       80             -4.4%               16        
  ZIXI    Zix Corporation                  Spurr, Richard D                 D        28,995      86             -7.3%               14        
  FNSR    Finisar Corporation              Swanson, Todd                    O        6,183       80             -11.5%              23        
  KWR     Quaker Chemical Corporation      Platzer, L Wilbert               O        5,621       75             -4.9%               19        
  NKTR    Nektar Therapeutics              Chess, Robert Bruce              D        5,000       94             -10.0%              23        
  JLL     Jones Lang Lasalle Inc.          Penrose, Sheila A                D        1,000       99             -21.8%              9         

The insider buying report presents recent insider purchases, reported on Forms 3, 4, and 5 filed with the SEC. The transactions are aggregated to a 'decision' level which simplifies the data analysis. A decision is a grouping of buying or selling by an individual at the specified company.

Bottomline Technologies, Inc. (NASDAQ:EPAY) - Bottomline Technologies (de), Inc. provides hosted or Software as a Service solutions for various industries worldwide. It operates through four segments: Payments and Transactional Documents, Hosted Solutions, Digital Banking, and Other. The company s products and services include Paymode-X, a cloud-based payment network that offers electronic payments and remittance delivery, online access to payment detail and reports, online payment approvals, electronic invoice delivery, and turnkey vendor enrollment and support; and digital banking solutions that provide payments, cash management, and online banking solutions to financial institutions, including banks and credit unions. It also provides legal spend management solutions, which integrate with claims management, and time and billing systems to automate legal invoice management processes; cyber fraud and risk management solutions that monitor, replay, and analyze user behavior to flag and stop suspicious activity in real time; and financial messaging solutions that enable corporations exchange financial information, such as payment instructions, cash reporting, and other messages related to financial transaction with their banks and counterparties. In addition, the company offers payment automation solutions to generate a range of payment instructions along with consolidated bank reporting of cash activity; payment and document automation solutions to automate a range of business documents and supply chain processes, as well as related Web-based delivery and document archive; and healthcare solutions for patient registration, electronic signature, mobile document, and payments. Further, it provides consulting, project implementation, and training services; and sells printers, check papers, and magnetic ink character recognition toners. The company was founded in 1989 and is headquartered in Portsmouth, New Hampshire..

Zix Corporation (NASDAQ:ZIXI) - Zix Corporation provides email encryption, data loss prevention (DLP), and Bring-Your-Own-Device (BYOD) security solutions to the healthcare, financial services, insurance, and government sectors in the United States. The company offers Zix Email Encryption that allows an enterprise to use policy-driven rules to determine email messages that should be sent securely to comply with regulations or company-defined policies. It also provides ZixDirectory, an email encryption community to share identities; Best Method of Delivery, a patented solution designed to deliver email based on the sender s and recipient s communications environment and preferences; and ZixGateway, which automatically encrypts and decrypts messages with sensitive content. In addition, the company offers ZixQuarantine, an email-specific data loss prevention solution that reduces deployment time; and ZixOne, a mobile email app, which provides access to corporate email while never allowing that data to be persistently stored on the device where it is vulnerable to loss or theft. Zix Corporation sells its email encryption, DLP, and ZixOne services through a direct sales force, and a network of resellers and other distribution partners. The company was formerly known as ZixIt Corporation and changed its name to Zix Corporation in 2002. Zix Corporation was founded in 1983 and is headquartered in Dallas, Texas..

Finisar Corporation (NASDAQ:FNSR) - Finisar Corporation provides optical subsystems and components for data communication and telecommunication applications in the United States, Malaysia, China, and internationally. Its optical subsystems primarily consist of transmitters, receivers, transceivers, transponders, and active optical cables that provide the fundamental optical-electrical or optoelectronic interface for interconnecting the electronic equipment used in communication networks, including the switches, routers, and servers used in wireline networks, as well as the antennas and base stations used in wireless networks. The company also offers wavelength selective switches, which are used to switch network traffic from one optical fiber to multiple other fibers without converting to an electronic signal. In addition, it provides optical components comprising packaged lasers, receivers, and photodetectors for data communication and telecommunication applications; and passive optical components for telecommunication applications. Finisar Corporation markets its products through its direct sales force, as well as through a network of distributors and manufacturers representatives to the original equipment manufacturers of storage systems, networking equipment, and telecommunication equipment, as well as to their contract manufacturers. Finisar Corporation was founded in 1987 and is headquartered in Sunnyvale, California..

Quaker Chemical Corporation (NYSE:KWR) - Quaker Chemical Corporation develops, produces, and markets various formulated chemical specialty products for various heavy industrial and manufacturing applications worldwide. Its products include rolling lubricants used by manufacturers of steel in the hot and cold rolling of steel, and aluminum in the hot rolling of aluminum; machining and grinding compounds for use in cutting, shaping, and grinding metal parts; hydraulic fluids for steel, metalworking, and other customers to operate hydraulic equipment; corrosion preventives to protect metals during manufacture, storage, and shipment; and specialty greases used in automotive production processes, steel manufacturing, and various other applications. The company also provides metal finishing compounds to prepare metal surfaces for special treatments, such as galvanizing and tin plating, as well as to prepare metal for further processing; forming compounds used to facilitate the drawing and extrusion of metal products; chemical milling maskants for the aerospace industry; and temporary and permanent coatings for metal and concrete products. In addition, it offers construction products comprising flexible sealants and protective coatings for various applications; bio-lubricants for forestry and construction industries; die casting lubricants; and chemical management services. The company serves steel, aluminum, automotive, mining, aerospace, tube and pipe, cans, and other industries. It markets and sells its products directly, as well as through distributors and agents. The company was formerly known as Quaker Chemical Products Corporation and changed its name to Quaker Chemical Corporation in August 1962. Quaker Chemical Corporation was founded in 1918 and is headquartered in Conshohocken, Pennsylvania..

Nektar Therapeutics (NASDAQ:NKTR) - Nektar Therapeutics develops drug candidates based on its PEGylation and polymer conjugate technology platforms in the United States. Its product pipeline includes drug candidates in therapeutic areas comprising cancer, auto-immune disease, and chronic pain. The company offers MOVANTIK, an oral peripherally-acting opioid antagonist for the treatment of opioid-induced constipation in adult patients with chronic non-cancer pain; MOVENTIG for the treatment of opioid-induced constipation in adult patients who have an inadequate response to laxatives; and ADYNOVATE for use in treating Hemophilia A. Its drug candidates in clinical development stage comprises BAY41-6551, which is in Phase III clinical trial to treat gram-negative pneumonias; NKTR-214 that is in Phase 1/2 stage to treat cancer; NKTR-181 that is in Phase III clinical trial for treating chronic pain; and NKTR-358 to treat autoimmune diseases. The company s drug candidates in clinical development stage also include ONZEALD, a topoisomerase I inhibitor that is in Phase III clinical trial for metastatic breast cancer, as well as completed Phase II clinical trial stage for refractory ovarian cancer and second-line metastatic colorectal cancer; and in combination with 5-fluorouracil/leucovorin to treat refractory solid tumor cancers, which has completed Phase I clinical trial. In addition, it holds license, manufacturing, and supply agreements with Ophthotech Corporation for Fovista; and UCB Pharma for dapirolizumab pegol. Further, the company holds a range of license, manufacturing, and supply agreements with other biotechnology and pharmaceutical companies, including Amgen Inc.; Allergan, Inc.; Merck & Co., Inc.; Pfizer, Inc.; and F. Hoffmann-La Roche Ltd (Roche). Nektar Therapeutics was founded in 1990 and is headquartered in San Francisco, California..

Jones Lang Lasalle Inc. (NYSE:JLL) - Jones Lang LaSalle Incorporated, a financial and professional services company, provides commercial real estate and investment management services worldwide. It offers a range of real estate services, including agency leasing, project and development management/construction, capital markets, property management, corporate finance, real estate investment banking/merchant banking, energy and sustainability services, research, facility management outsourcing, strategic consulting, technology solutions, advisory services, investment management, tenant representation, lease administration, transaction management, logistics and supply-chain management, valuations, mortgage origination and servicing, and value recovery and receivership services. The company also provides investment management services to institutional and retail investors, including high-net-worth individuals. It offers its services to real estate owners, occupiers, investors, and developers for various property types, including cultural, educational, government, healthcare, laboratory, hotel, hospitality, and sports facilities; industrial, warehouse, office, residential, and retail properties; critical environments, data, and transportation centers; infrastructure projects; military housing; and shopping malls. The company was formerly known as LaSalle Partners Incorporated and changed its name to Jones Lang LaSalle Incorporated in March 1999. Jones Lang LaSalle Incorporated was founded in 1997 and is headquartered in Chicago, Illinois..

About BUYINS.NET

BUYINS.NET, http://www.buyins.net, monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market-maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include:

REGULATORY & COMPLIANCE NEWS Friction Factor - Market maker surveillance system tracking Level II market makers in all stocks to determine Price Friction and compliance with new "Fair Market Making Requirements" Naked Shorts (RegSho) - Tracks EVERY failure to deliver in all US stocks and tracks all Threshold Security Lists daily for which stocks have naked shorts that are not in compliance with Regulation SHO

INVESTMENTS & TRADING Earnings - Predicts probability, price move and length of move before and after all US stock earnings reports Seasonality - Predicts probability, price move and length of move based on exact time of year for all US stocks Group Correlation - Tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups SqueezeTrigger - Massive database that tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock. Valuation - Tracks all known valuation models and applies them. GATS - Tracks and quantifies known trading strategies by backtesting, optimizing and running genetic algorithms and neural networks to ascertain best trading strategies. PatternScan - Automates tracking of every technical pattern and predicts next move in stocks. Insider - Tracks insiders trading records and determines trading performance. Trades by higher-level insiders are generally more predictive than trades by lower level insiders Events - Tracks patterns directly correlated to specific events.

SqueezeTrigger is a registered trademark, Reg. No. 3,120,641

DISCLAIMER:

BUYINS.NET is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell any securities. [symbol] has not approved the statements made in this release. Please read our report and visit our web site, http://www.buyins.net, for complete risks and disclosures.

Contact: BUYINS.NET Thomas Ronk 800-715-9999 tom@buyins.net http://www.buyins.net

Contributing Sources

---